You are here
A study from the British Society for Rheumatology Biologics Register in Axial Spondyloarthritis (BSRBR-AS) shows that biologic use significantly improves work productivity and overall activity impairment.
The BSRBR-AS registry analyzed 577 participants who were employed; 28% were started on biological therapy .
After 12-months of follow-up, those receiving biologic therapy had significantly greater improvements (relative to non-biological therapy) in presenteeism, overall work impairment, and overall activity impairment; however there was no difference in absenteeism.
There is consistent evidence that treatment with biological therapy improves these work and activity measures.